BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19818580)

  • 1. Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction.
    Passot G; Glehen O; Pellet O; Isaac S; Tychyj C; Mohamed F; Giammarile F; Gilly FN; Cotte E
    Eur J Surg Oncol; 2010 Mar; 36(3):315-23. PubMed ID: 19818580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.
    Dubreuil J; Giammarile F; Rousset P; Bakrin N; Passot G; Isaac S; Glehen O; Skanjeti A
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1630-7. PubMed ID: 26907364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
    Hotta M; Minamimoto R; Gohda Y; Igari T; Yano H
    Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.
    Marcotte E; Dubé P; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Sideris L
    World J Surg Oncol; 2014 Nov; 12():332. PubMed ID: 25380618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Effectiveness of Preoperative 18F-FDG PET/CT in Predicting Pathological Tumor Grade in Patients with Pseudomyxoma Peritonei Originating from Appendix: A Retrospective Cohort Study.
    Aso K; Gohda Y; Hotta M; Minamimoto R; Shimizu Y; Uemura Y; Yano H
    Ann Surg Oncol; 2024 Mar; 31(3):1990-1995. PubMed ID: 38082170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
    Lu YY; Guo AT; Liu AJ; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
    Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
    Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritonei.
    Flood MP; Kong JC; Pham T; Waters PS; Soucisse M; Ramsay R; Wong HL; Mitchell C; Michael M; McCormick JJ; Warrier SK; Akhurst T; Heriot AG
    Eur J Surg Oncol; 2022 Jul; 48(7):1606-1613. PubMed ID: 35148916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of preoperative sonography in the diagnosis and pathologic staging of pseudomyxoma peritonei.
    Li Y; Guo A; Tang J; Wang L; Wang J; Yu D
    J Ultrasound Med; 2013 Sep; 32(9):1565-70. PubMed ID: 23980216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huge pseudomyxoma peritonei: Surgical strategies and procedures to employ to optimize the rate of complete cytoreductive surgery.
    Benhaim L; Honoré C; Goéré D; Delhorme JB; Elias D
    Eur J Surg Oncol; 2016 Apr; 42(4):552-7. PubMed ID: 26868165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Arjona-Sanchez A; Muñoz-Casares FC; Casado-Adam A; Sánchez-Hidalgo JM; Ayllon Teran MD; Orti-Rodriguez R; Padial-Aguado AC; Medina-Fernández J; Ortega-Salas R; Pulido-Cortijo G; Gómez-España A; Rufián-Peña S
    World J Surg; 2013 Jun; 37(6):1263-70. PubMed ID: 23532601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings.
    Low RN; Barone RM; Gurney JM; Muller WD
    AJR Am J Roentgenol; 2008 Mar; 190(3):656-65. PubMed ID: 18287436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating pseudomyxoma peritonei without heated intraperitoneal chemotherapy--a first look in New Zealand.
    Wheeler BR; Reddy SK; Kenwright D; Keating JP
    N Z Med J; 2014 Feb; 127(1389):31-9. PubMed ID: 24548955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
    Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
    De Vos N; Goethals I; Ceelen W
    Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.
    Dineen SP; Royal RE; Hughes MS; Sagebiel T; Bhosale P; Overman M; Matamoros A; Mansfield PF; Fournier KF
    Ann Surg Oncol; 2015 Oct; 22(11):3640-6. PubMed ID: 25698402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved.
    Dayal S; Taflampas P; Riss S; Chandrakumaran K; Cecil TD; Mohamed F; Moran BJ
    Dis Colon Rectum; 2013 Dec; 56(12):1366-72. PubMed ID: 24201390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.